Answers are grounded in this paper and cite their sources.
Adenocarcinoma with enteroblastic differentiation (AED) is a rare and aggressive gastrointestinal malignancy. We describe a fatal disease in a 34-year-old male patient who presented with a gastroesophageal junction (GEJ) mass and synchronous liver metastases. The patient's serum alpha-fetoprotein (AFP) level was markedly elevated (30 000 ng/mL). Histopathologic examination revealed carcinoma with fetal gut-like morphology and immunoreactivity for SALL4 and AFP, confirming the diagnosis. This patient is notable for the exceptionally young age, expanding the recognized demographic spectrum of this tumor. It underscores the diagnostic challenge of distinguishing AED from germ cell tumors, a distinction that critically influences treatment strategy and prognosis. The rapidly fatal course highlights the aggressive nature of this entity and the urgent need for better diagnostic awareness and more effective therapeutic options.
No takes yet. Share an insight, caveat, or question.
Baban et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: